{
    "title": "FDA weighs approval of first-in-class cholesterol drug",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3112451/FDA-weighs-approval-class-cholesterol-drug.html",
    "date": "2015-06-05",
    "keywords": [
        "cholesterol",
        "drug",
        "approval",
        "study",
        "praluent",
        "class",
        "fda",
        "statin",
        "inc",
        "heart",
        "percent",
        "gmt",
        "june",
        "blockbuster",
        "company",
        "benefit",
        "death",
        "ability",
        "substance",
        "agency",
        "panel",
        "tuesday",
        "condition",
        "regeneron",
        "firstinclass",
        "press",
        "email",
        "washington",
        "health",
        "friday",
        "measure",
        "food",
        "administration",
        "review",
        "meeting",
        "week",
        "biotech",
        "advance",
        "introduction",
        "ldl",
        "disease",
        "control",
        "prevention",
        "risk",
        "diseaseacross",
        "addition",
        "fall",
        "dose",
        "reduction",
        "alonebut",
        "cholesterollowering",
        "waxlike",
        "bloodstream",
        "example",
        "pfizer",
        "torcetrapib",
        "win",
        "analyst",
        "matthew",
        "roden",
        "research",
        "note",
        "downside",
        "documentmany",
        "yearthe",
        "repatha",
        "amgen",
        "lowdensity",
        "lipoprotein",
        "way",
        "pcsk9",
        "bloodbut",
        "prospect",
        "zocor",
        "lipitor",
        "genericssanofi",
        "partner",
        "group",
        "voice",
        "benefitsnext",
        "recommendation",
        "decision",
        "july",
        "sanofi",
        "york"
    ],
    "category": [
        "wires",
        "ap"
    ]
}